|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Equity-based compensation | |||||
| Amortization of debt discount and issuance costs | |||||
| Debt issuance cost write offs | |||||
| Gain on repurchase of exchangeable notes | |||||
| Net gain on sale of investments | |||||
| Gain on sale of businesses | |||||
| Write down of intangible asset | |||||
| Provision for (Benefit from) deferred income taxes | |||||
| Non-cash lease expense | |||||
| Other non-cash adjustments to net income (loss) | |||||
| Increase (Decrease) in non-cash contingent consideration expense from original estimate | |||||
| Changes in operating assets: | |||||
| Accounts receivable | |||||
| Other assets | |||||
| Changes in operating liabilities: | |||||
| Accounts payable | |||||
| Acquisition escrow obligations | |||||
| Settlement obligations | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Other long-term liabilities | |||||
| Contingent consideration paid in excess of original estimates | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Expenditures for property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Expenditures for capitalized software | |||||
| Purchases of merchant portfolios and residual buyouts | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Proceeds from sale of Merchant Services Business, net of cash sold | |||||
| Merchant Services Business | |||||
| Healthcare RCM Business | |||||
| Total proceeds from sale of Merchant Services Business, net of cash sold | |||||
| Payments for other investing activities | |||||
| Proceeds from investments | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from revolving credit facility | |||||
| Payments on revolving credit facility | |||||
| Payments to extinguish exchangeable notes | |||||
| Payments for repurchase of exchangeable notes | |||||
| Proceeds from sale of exchangeable senior note hedges | |||||
| Payments for repurchases of warrants | |||||
| Payments of debt issuance costs | |||||
| Proceeds from issuance of Class A common stock, net of underwriting discounts and offering costs | |||||
| Payments of equity issuance costs | |||||
| Payments for repurchases of Class A common stock | |||||
| Net payments for settlement obligations | |||||
| Cash paid for contingent consideration | |||||
| Payments for required distributions to members or on behalf of members for tax obligations | |||||
| Payments for required distributions to members under the Tax Receivable Agreement | |||||
| Proceeds from stock option exercises | |||||
| Payments for employee's tax withholdings from net settled stock option exercises and RSU releases | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds | |||||
Loading...